Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platelet Coagulation Disorders”

969 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 969 results

Testing effectiveness (Phase 2)Looking for participantsNCT07043946
What this trial is testing

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITPBiologics+2 more
Climb Bio, Inc. 24
Not applicableStudy completedNCT03820960
What this trial is testing

Risk Factors for Thrombosis in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
University Hospital, Toulouse 10,039
Testing effectiveness (Phase 2)Study completedNCT00001596
What this trial is testing

Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

Who this might be right for
AlbinismInborn Errors of MetabolismOculocutaneous Albinism+2 more
William Gahl, M.D. 35
Not applicableStudy completedNCT03469661
What this trial is testing

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Immune ThrombocytopeniaMyelodysplastic Syndromes
Fundacion CRIS de Investigación para Vencer el Cáncer 63
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT02460458
What this trial is testing

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

Who this might be right for
Type 3 Von Willebrand's Disease
Fondazione Angelo Bianchi Bonomi 265
Not applicableStudy completedNCT06433778
What this trial is testing

A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

Who this might be right for
Von Willebrand Disease (VWD)
Takeda 34
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Active Not RecruitingNCT02577926
What this trial is testing

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

Who this might be right for
Polycythemia Vera (PV)Essential Thrombocythemia (ET)
RWTH Aachen University 207
Testing effectiveness (Phase 2)Looking for participantsNCT07095127
What this trial is testing

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Nuvig Therapeutics, Inc. 10
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT04269603
What this trial is testing

LTA Assessement Using Aggregometer TA-8V (Stago®)

Who this might be right for
Healthy Volunteer
Hospices Civils de Lyon 34
Testing effectiveness (Phase 2)Study completedNCT00162006
What this trial is testing

Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Baxalta now part of Shire 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04081220
What this trial is testing

Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2

Who this might be right for
Thrombocythemia, Essential
The University of Texas Health Science Center at San Antonio 9
Large-scale testing (Phase 3)Study completedNCT00362349
What this trial is testing

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
CSL Limited 19
Not applicableStudy completedNCT05695560
What this trial is testing

A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their Caregivers

Who this might be right for
Von Willebrand Disease (VWD)
Takeda 12
Large-scale testing (Phase 3)UnknownNCT01805648
What this trial is testing

Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Peking Union Medical College 120
Testing effectiveness (Phase 2)Looking for participantsNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Load More Results